Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Long- versus short-duration systemic corticosteroid regimens for acute exacerbations of COPD: A systematic review and meta-analysis of randomized trials and cohort studies

Zhen Zhao, Owen Lou, Yiyang Wang, Raymond Yin, Carrie Gong, Florence Deng, Ethan C Wu, Jing Yi Xie, Jerry Wu, Avery Ma, Yongzhi Guo, Wei Ting Xiong
doi: https://doi.org/10.1101/2023.09.12.23295446
Zhen Zhao
1Western University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: markzhao2{at}gmail.com
Owen Lou
2McMaster University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yiyang Wang
3University of California, Los Angeles
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raymond Yin
1Western University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carrie Gong
4Bayview Secondary School
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Florence Deng
2McMaster University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ethan C Wu
5Sir Winston Churchill High School
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jing Yi Xie
2McMaster University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jerry Wu
3University of California, Los Angeles
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Avery Ma
6Collège Charlemagne
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yongzhi Guo
7University of Toronto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wei Ting Xiong
7University of Toronto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

Abstract

While systemic corticosteroids quicken patient recovery during acute exacerbations of COPD, they also have many adverse effects. The optimal duration of corticosteroid administration remains uncertain. We performed a systematic review and meta-analysis to compare patient outcomes between short-(≤7 day) and long- (>7 day) corticosteroid regimens in adults with acute exacerbations of COPD.

MEDLINE, EMBASE, CENTRAL, and hand searches were used to identify eight eligible RCTs and three retrospective cohort studies. Risk of bias was assessed using the Cochrane RoB 2.0 tool and ROBINS-I. Data were summarized as odds ratios (ORs) or mean differences (MDs) whenever possible and qualitatively described otherwise.

A total of 11532 participants were included, with 1296 eligible for meta-analyses. Heterogeneity was present in the methodology and settings of the studies. The OR for mortality was 0.76 (95% CI=0.40–1.44, n=1055). The MD for hospital length-of-stay was -0.91 days (95% CI=-1.81–-0.02 days, n=421). The OR for re-exacerbations was 1.31 (95% CI=0.90–1.90, n=552). The OR for hyperglycemia was 0.90 (95% CI=0.60–1.33, n=423). The OR for infection incidence was 0.96 (95% CI=0.59–1.156, n=389). The MD for one-second forced expiratory volume change was -18.40 mL (95% CI=-111.80–75.01 mL, n=161).

The RCTs generally had low or unclear risks of bias, while the cohort studies had serious or moderate risks of bias. Our meta-analyses were affected by imprecision due to insufficient data. Some heterogeneity was present in the results, suggesting population, setting, and treatment details are potential prognostic factors. Our evidence suggests that short-duration treatments are not worse than long-duration treatments in moderate/severe exacerbations and may lead to considerably better outcomes in milder exacerbations. This supports the current GOLD guidelines for corticosteroid administration.

No funding was given for this review. Our protocol is registered in PROSPERO: CRD42023374410.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Protocols

https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=374410

Funding Statement

This study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study used ONLY openly available human data that were originally taken from the previous studies included in this systematic review

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted September 13, 2023.
Download PDF
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Long- versus short-duration systemic corticosteroid regimens for acute exacerbations of COPD: A systematic review and meta-analysis of randomized trials and cohort studies
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Long- versus short-duration systemic corticosteroid regimens for acute exacerbations of COPD: A systematic review and meta-analysis of randomized trials and cohort studies
Zhen Zhao, Owen Lou, Yiyang Wang, Raymond Yin, Carrie Gong, Florence Deng, Ethan C Wu, Jing Yi Xie, Jerry Wu, Avery Ma, Yongzhi Guo, Wei Ting Xiong
medRxiv 2023.09.12.23295446; doi: https://doi.org/10.1101/2023.09.12.23295446
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Long- versus short-duration systemic corticosteroid regimens for acute exacerbations of COPD: A systematic review and meta-analysis of randomized trials and cohort studies
Zhen Zhao, Owen Lou, Yiyang Wang, Raymond Yin, Carrie Gong, Florence Deng, Ethan C Wu, Jing Yi Xie, Jerry Wu, Avery Ma, Yongzhi Guo, Wei Ting Xiong
medRxiv 2023.09.12.23295446; doi: https://doi.org/10.1101/2023.09.12.23295446

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Respiratory Medicine
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)